Survival is an important outcome measure of successful treatment in medical research. Survival is predominantly analyzed by Kaplan-Meier estimation and requires two data points: status (deceased or alive) and delta time. In retrospective studies and studies with large populations, the Social Security Death Index (SSDI), based on the Social Security Administration's Death Master File, is an established and inexpensive method to evaluate the current status of patients and to close gaps during follow-up. This study aims to compare the SSDI methodology with our institutional multimodal methodology (Aortic Institute Methodology [AIM]).
PATIENTS AND METHODS Study Design
Five recent retrospective studies from our institute including aortic and aortic valve diseases, treated between 2000 and 2015, were merged, and survival follow-up was assessed and compared using two different methods for each patient (SSDI query [December 29-31, 2015] vs our multimodal Aortic Institute Methodology [AIM; April 2014 to December 2015]). Only US citizens and patients who had a Social Security Number (SSN) were included. The Human Investigation Committee of Yale University approved this retrospective study.
Follow-up of the SSDI group was achieved using the online available open source Death Master File of the Social Security Administration.
1,2 The query entry items included SSN and name and date of birth (AE1 day). The status ''alive'' was set as of the date of the query.
The AIM for retrospective studies is based on the following sequential steps:
1. An online database query, available from free websites such as SSDI query 1 and MooseRoots. 
Statistics
Performance measures were analyzed by comparing the SSDI method with the AIM method. Survival difference according to methodology was estimated by Kaplan-Meier survival estimation and compared using the Mantel-Cox log rank test. The prevalence-independent measure, the negative likelihood ratio (ÀLR), was computed; a lower value implies a greater chance a death truly did not occur.
RESULTS

Identified Patients
The numbers of deceased patients who were identified according to each method are shown in Figure 1 . The performance measures of the SSDI (compared with the FIGURE 1. Number of deceased patients identified according to each methodology. The institutional method is transitioned, evaluating the non-expired patients by descending order of steps. SSDI, Social Security Death Index. FIGURE 2. Kaplan-Meier survival estimation analyzing the identical population but using different follow-up methodologies. SSDI survival is estimated using the date of the query as status ''alive.'' The AIM methodology is presented with both the date of the query and the date of the last proven contact as status ''alive.'' SSDI, Social Security Death Index.
AIM) were as follows (95% confidence interval [CI]):
(1) sensitivity, 42.7% (35.1%-50.5%) and (2) ÀLR, 57.3% (50.4%-65.2%) ( Table 2) . Excluding patients who died within the barred years (2013-2015), the performance measures were as follows (95% CI): (1) sensitivity, 58.4% (49.3%-67.1%) and (2) ÀLR, 41.6% (33.8%-51.2%).
Specificity was 100% throughout.
Survival and Length of Follow-up
The survival estimates, determined with the two methodologies for the same patients, differed significantly (P <.0001) (Figure 2) . The mean follow-up times were as follows: SSDI, 70.0 AE 46.9 months; AIM (query status ''alive''), 63.1 AE 44.9 months; and AIM (clinical contact status ''alive''), 42.6 AE 42.9 months.
DISCUSSION
In the present era, a multimodal assessment of survival estimation is significantly superior to sole use of SSDI open sources. The SSDI was formerly supplied by federal and state sources, but since November 2011 death information received from the states was not made public. 4 Also, legislative rules governing the SSDI have changed, so that records from the most recent 3-year period are not available through publicly accessible free online services.
5 Negative LRs, which are not affected by the prevalence of the outcome (ie, death, which can vary proportionally with age), were 57.3% for the total timeframe and 41.6% excluding the barred period, indicating that currently the SSDI fails to detect death adequately. The National Death Index by the Centers for Disease Control and Prevention could be an alternative source of survival data besides the described multimodality follow-up; however, it is a costly resource and time delayed. 4 Above and beyond the methodology, the date of status ''alive'' significantly affects estimated survival. Although using the query date overestimates survival, the date of the last proven contact may underestimate it, even if the data are more solid. The real survival will most likely be between those curves, and close to the ''last proven contact'' curve.
Moving, change of contact data, and international patients (excluded) are the limiting factors of such multimodular methodology; however, using the last clinical contact as status ''alive'' diminishes such limitations.
We conclude that the sole use of the SSDI feigns a better survival and, thus, is not adequate for survival estimation in medical studies.
